Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress

Meng,Xiaoyin; Chen,Hongguang; Wang,Guolin; Yu,Yonghao; Xie,Keliang

doi:10.3892/etm.2015.2787

Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress

Authors:
- Xiaoyin Meng
- Hongguang Chen
- Guolin Wang
- Yonghao Yu
- Keliang Xie
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, Tianjin Hospital, Tianjin 300052, P.R. China, Department of Anesthesiology, Tianjin Institute of Anesthesiology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
Published online on: October 5, 2015 https://doi.org/10.3892/etm.2015.2787
Pages: 2277-2282

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hydrogen has been reported to exert a therapeutic effect in several diseases due to its antioxidative, anti-inflammatory and anti-apoptotic properties. The aim of the present study was to investigate whether hydrogen‑rich saline treatment could attenuate ovarian damage induced by cisplatin. A total of 240 adult, virgin, female Sprague Dawley rats, weighing 180‑220 g, were randomly divided into four groups (n=60 per group): Control (Con), control + hydrogen‑rich saline (Con + H2), cisplatin‑induced ovarian injury (OI) and cisplatin‑induced ovarian injury + hydrogen‑rich saline (OI + H2). Cisplatin was diluted in saline immediately before use. In the OI and OI + H2 groups, the rats were administered a dose of cisplatin on the 1st and 7th days. The rats in the Con + H2 and OI + H2 groups were intraperitoneally injected with hydrogen‑rich saline (10ml/kg body weight) once a day over a 2‑week period. On the 14th, 28th and 42nd days (T1, T2 and T3) after the cisplatin injection, femoral vein blood was collected. At the end of the experiment, ovarian homogenates were prepared, and the samples were used for estrogen (E2), follicle‑stimulating hormone (FSH), superoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) examination. In addition, rats (n=10 per group) were sacrificed for bilateral ovary removal; one was fixed in formalin for follicle‑counting analysis, while the other was used for nuclear factor erythroid 2‑related factor 2 (Nrf2) detection by western blotting. Hydrogen‑rich saline attenuated the FSH release, elevated the level of E2, improved the development of follicles, and reduced the damage to the ovarian cortex at T1, T2 and T3 in the OI + H2 rats. Cisplatin induced oxidative stress by increasing the levels of oxidation products and attenuating the activity of antioxidant enzyme, which could be reversed by hydrogen‑rich saline treatment. Furthermore, hydrogen‑rich saline regulated the Nrf2 protein expression in rats with ovarian damage. In conclusion, hydrogen‑rich saline exerts a protective effect against cisplatin-induced ovarian injury by reducing MDA and increasing SOD and CAT activity. Ovarian injury induced by chemotherapy involves the activation of Nrf2.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66. 2007. View Article : Google Scholar : PubMed/NCBI
2	Lee HJ, Selesniemi K, Niikura Y, Niikura T, Klein R, Dombkowski DM and Tilly JL: Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol. 25:3198–3204. 2007. View Article : Google Scholar : PubMed/NCBI
3	Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL, Wu H, Patel R, Liu D, Qin ZH, Shih IM and Yang JM: NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene. 31:1055–1064. 2012. View Article : Google Scholar : PubMed/NCBI
4	Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, et al: Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol. 28:1145–1153. 2010. View Article : Google Scholar : PubMed/NCBI
5	Bae-Jump VL, Zhou C, Boggess JF and Gehrig PA: Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. Cancer. 115:3887–3896. 2009. View Article : Google Scholar : PubMed/NCBI
6	Hu J and Friedman E: Depleting Mirk kinase increases cisplatin toxicity in ovarian cancer cells. Genes Cancer. 1:803–811. 2010. View Article : Google Scholar : PubMed/NCBI
7	Morgan S, Lopes F, Gourley C, Anderson RA and Spears N: Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLoS One. 8:e701172013. View Article : Google Scholar : PubMed/NCBI
8	Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L and Wang G: Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock. 34:90–97. 2010. View Article : Google Scholar : PubMed/NCBI
9	Xie K, Yu Y, Zhang Z, Liu W, Pei Y, Xiong L, Hou L and Wang G: Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock. 34:495–501. 2010. View Article : Google Scholar : PubMed/NCBI
10	Qu J, Li X, Wang J, Mi W, Xie K and Qiu J: Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress. Int J Pediatr Otorhinolaryngol. 76:111–115. 2012. View Article : Google Scholar : PubMed/NCBI
11	Matsushita T, Kusakabe Y, Kitamura A, Okada S and Murase K: Investigation of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using blood oxygenation level-dependent magnetic resonance imaging. Jpn J Radiol. 29:503–512. 2011. View Article : Google Scholar : PubMed/NCBI
12	Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S and Ohta S: Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 64:753–761. 2009. View Article : Google Scholar : PubMed/NCBI
13	Zheng X, Mao Y, Cai J, Li Y, Liu W, Sun P, Zhang JH, Sun X and Yuan H: Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats. Free Radic Res. 43:478–484. 2009. View Article : Google Scholar : PubMed/NCBI
14	Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S, et al: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 373:30–35. 2008. View Article : Google Scholar : PubMed/NCBI
15	Li X, Yang S, Lv X, Sun H, Weng J, Liang Y and Zhou D: The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats. J Gynecol Oncol. 24:177–185. 2013. View Article : Google Scholar : PubMed/NCBI
16	Dale O, Mortensen B, Thommesen L and Hagen B: Cisplatin toxicity in the rat may be influenced by anaesthetic agents. Acta Anaesthesiol Scand. 44:7702000. View Article : Google Scholar : PubMed/NCBI
17	Oktay K, Schenken RS and Nelson JF: Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat. Biol Reprod. 53:295–301. 1995. View Article : Google Scholar : PubMed/NCBI
18	Cheng X, Ku CH and Siow RC: Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis. Free Radic Biol Med. 64:4–11. 2013. View Article : Google Scholar : PubMed/NCBI
19	Li Y, Li X, Wong YS, Chen T, Zhang H, Liu C and Zheng W: The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis. Biomaterials. 32:9068–9076. 2011. View Article : Google Scholar : PubMed/NCBI
20	Belotte J, Fletcher NM, Awonuga AO, Alexis M, Abu-Soud HM, Saed MG, Diamond MP and Saed GM: The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer. Reprod Sci. 21:503–508. 2014. View Article : Google Scholar : PubMed/NCBI
21	Dole M, Wilson FR and Fife WP: Hyperbaric hydrogen therapy: A possible treatment for cancer. Science. 190:152–154. 1975. View Article : Google Scholar : PubMed/NCBI
22	Saitoh Y, Yoshimura Y, Nakano K and Miwa N: Platinum nanocolloid-supplemented hydrogen-dissolved water inhibits growth of human tongue carcinoma cells preferentially over normal cells. Exp Oncol. 31:156–162. 2009.PubMed/NCBI
23	Oyawoye O, Gadir Abdel A, Garner A, Constantinovici N, Perrett C and Hardiman P: Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: Relationship to outcome. Hum Reprod. 18:2270–2274. 2003. View Article : Google Scholar : PubMed/NCBI
24	Crha I, Hrubá D, Ventruba P, Fiala J, Totusek J and Visnová H: Ascorbic acid and infertility treatment. Cent Eur J Public Health. 11:63–67. 2003.PubMed/NCBI
25	Carbone MC, Tatone C, Delle Monache S, Marci R, Caserta D, Colonna R and Amicarelli F: Antioxidant enzymatic defences in human follicular fluid: Characterization and age-dependent changes. Mol Hum Reprod. 9:639–643. 2003. View Article : Google Scholar : PubMed/NCBI
26	Török A, Belágyi J, Török B, Tinneberg HR and Bódis J: Scavenger capacity of follicular fluid, decidua and culture medium with regard to assisted reproduction: An in vitro study using electron paramagnetic resonance spectroscopy. Gynecol Obstet Invest. 55:178–182. 2003. View Article : Google Scholar : PubMed/NCBI
27	Cohen M, Lippman M and Chabner B: Role of pineal gland in aetiology and treatment of breast cancer. Lancet. 2:814–816. 1978. View Article : Google Scholar : PubMed/NCBI
28	Matzuk MM, Dionne L, Guo Q, Kumar TR and Lebovitz RM: Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology. 139:4008–4011. 1998. View Article : Google Scholar : PubMed/NCBI
29	Nguyen T, Yang CS and Pickett CB: The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med. 37:433–441. 2004. View Article : Google Scholar : PubMed/NCBI
30	Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M and Talalay P: Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA. 99:11908–11913. 2002. View Article : Google Scholar : PubMed/NCBI
31	Hu X, Roberts JR, Apopa PL, Kan YW and Ma Q: Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice. Mol Cell Biol. 26:940–954. 2006. View Article : Google Scholar : PubMed/NCBI